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group; dP/dtmax was 999±253 mmHg/s at 120 min (p=0.016) and 854±209 mmHg/s at
180 min (p=0.054).
Conclusion: Induced maternal hyperglycemia improves fetal cardiac function during
fetal tachycardia. 
1057-201 Fetal Aortic Stenosis With Apex-Forming Left Ventricle 
at Time of Diagnosis: Determinants of Biventricular 
Repair
Masaki Nii, Rajiv Chaturvedi, Kevin Roman, Edgar T. Jaeggi, The Hospital for Sick 
Children, Toronto, Canada
Background: Aortic stenosis (AS) may result in impaired and preserved growth of the
left heart. Potential for biventricular repair is critical in counseling and management.
Objectives: To assess the value of markers in predicting suitability for biventricular (BV)
versus single ventricular (SV) repair in fetal AS.
Methods: Review of all cases of fetal AS, diagnosed at our center since 1995. Inclusion
criteria were 1) apex-forming left ventricle (LV) at time of diagnosis, 2) intact ventricular
septum, and 3) serial follow-up studies to birth. The following parameters were assessed
at diagnosis: Ventricular dimensions and systolic functions, orientation of aortic and
foraminal flows, and presence/absence of endocardial fibroelastosis. Analysis of the pul-
monary venous flow to assess diastolic function included peak velocity of reversed flow
during atrial systole (PVA), integrated time velocity ratio of early diastolic to ventricular
systolic forward flow (D/S), and the ratio of reversed to forward pulmonary venous flow
(A/(S+D)). Depending on the type of postnatal intervention, 2 patient groups were cre-
ated and the parameters compared.
Results. The baseline characteristics of 16 fetuses included in the study are shown. 
Conclusion: In AS with apex-forming LV at time of diagnosis functional indices (LV 
shortening; pulmonary vein flow) provide useful information in predicting left ventricular 
growth potential and suitability for biventricular repair.
1057-202 Changing Indications for Fetal Echocardiography in a 
University Center Population
Mark K. Friedberg, Norman H. Silverman, Stanford University, Stanford, CA
Background
Technical advances and obstetrical education have greatly increased the use of Fetal
Echocardiography (FE) over the past 10 years. Earlier studies showed that the major
indications for FE included a family history of congenital heart disease (CHD), maternal
diabetes and arrythmia. We hypothesized that the increased utilization of FE is associ-
ated with a change in indications and yield of FE.
Methods
We reviewed 300 consecutive FE performed at Stanford University between 12/2002 and
8/2003. Major anomaly was defined as that affecting prognosis.
Chromosomal anomaly was defined either as suspected (based on ultrasound (US) find-
ings) or proven (chromosomal analysis).
Results
Indications for FE and their yield are presented in the table. 
Mean maternal age was 31±6 (range 16-44) years. Of 7 cases with increased nuchal 
thickening, 1 (14%), showed PA/IVS. No cardiac anomalies were found in the presence of 
an abnormal umbilical cord.
Conclusions
Indications for FE have changed over the last 10 years. An obstetrical US suspicious for 
CHD has become a prominent indication for FE, indicating an increased awareness of 
cardiac anomalies by obstetricians. This indication, together with chromosomal 
anomalies, accounts for a large percentage of positive FE. Thus, the yield of FE depends 
to a large extent on the skills of the obstetrician. Common indications that continue to 
have relatively low yield include maternal diabetes, arrhythmia and especially a family 
history of CHD and exposure to a teratogen.
1057-203 Ventricular Function in Fetal Congestive Heart Failure 
and Predictors of Perinatal Outcome
Masaki Nii, Mary van der Velde, Edward N. Marcus, Wendy Tsang, Lisa K. Hornberger, 
The Hospital for Sick Children, Toronto, ON, Canada, Children's Hospital, Boston, MA
Background: Although the types of primary cardiac lesions associated with fetal con-
gestive heart failure (CHF) are well recognized, there is a paucity of data which defines
the associated abnormalities of ventricular function and predictors of outcome. We
sought to determine the specific abnormalities of ventricular function and to identify ven-
tricular functional parameters that may assist in predicting outcome in a large cohort of
affected fetuses. Methods: We reviewed the initial fetal echocardiograms (mean age
25.2±5.2 weeks) and clinical histories of 87 fetuses with CHF due to structural heart dis-
ease (n=41), primary dysrhythmias (n=22) or primary myocardial disease (n=24). LV and
RV shortening fraction (SF), and Tei indices were assessed where possible and com-
pared to previously published normal data. Diastolic dysfunction was considered to be
present when 1 or more of the following indices were abnormal: A/E ratio, deceleration
time, LV-IVRT, IVC, DV and UV flow pattern. In continued pregnancies with known out-
come, parameters were compared between those with fetal or neonatal demise (n=38)
versus survivors (n=26). Results: In the 87 cases of CHF, LV and RV SF were abnormal
in 49.4% and 64.9%, respectively and significantly decreased compared to normal
(LV=27.4±11.7, RV=23.8±11.8,p<0.05). LV and RV Tei-indices were abnormal in 53.1%
and 58.8%, respectively and overall were significantly increased (LV=0.64±0.42, p<0.01;
RV=0.65±0.45, p<0.01). RV SF was significantly lower than the LV (p=0.02) but the RV
and LV Tei-indices were not different. A/E ratio of both ventricles did not differ significantly
from normal (LV=1.31±0.48, RV=1.46±0.62), and RV and LV A/E ratios were not differ-
ent. Diastolic dysfunction was present in 39 of 50 cases with CHF assessed. Of all the
functional parameters compared, only LV SF was significantly decreased in fetuses with
fetal or neonatal demise versus survivors (28.4±10.5 vs 21.5±12.3, respectively, p=0.03).
Conclusion: In fetuses with CHF, RV and LV systolic dysfunction is present in 50-60%
and diastolic dysfunction in 78%. While RV systolic dysfunction is more common in CHF,
the presence of LV systolic dysfunction may further contribute to outcome.
1057-204 Outcome Following Prenatal Identification of Structural 
Heart Disease: A Seven-Year Experience
Geoffrey A. Forbus, Andrew M. Atz, Scott M. Bradley, Girish S. Shirali, Medical University 
of South Carolina, Charleston, SC
Background: This study evaluates outcome in a series of consecutive patients who were
diagnosed prenatally with structural heart defects (SHD) and identifies factors associated
with mortality in this cohort.
Methods: Fetal echo reports at a single institution from August 1995 through November
2002 were reviewed. The following outcomes for fetuses with SHD were evaluated: fami-
lies opting for no active management, hospital survival following surgery at initial admis-
sion, and survival at most recent follow up. Variables evaluated for potential association
with these outcomes included cardiac diagnosis, gestational age at diagnosis and at
birth, gender, birth weight, extracardiac and/or chromosomal anomalies, ethnicity, insur-
ance status (a marker of socioeconomic status), surgery at initial admission, and univen-
tricular versus biventricular management pathway. Univariate and multivariate analysis
were performed.
Results: We identified 168 fetuses with SHD, of whom 126 (75%) chose active treatment.
SV Repair
(n = 8)
BV Repair
(n = 8)
P-Values
Age at diagnosis 21.4+4.3 weeks 21.8+ 5.7 weeks NS
Increase in LV diameter 5/8 (63%) 4/8 (50%) NS
Endocardial fibroelastosis 7/8 (88%) 4/8 (50%) NS
LV shortening fraction 4.0±8.1 % 18.2±17.8 % 0.04
Retrograde aortic flow 3/8 (38%) 0/8 (0%) NS
Left-right atrial shunting 8/8 (100%) 5/8 (63%) NS
PVA reversal 35.4±9.8 cm/s 10.1±0.5 cm/s 0.0001
D/S TVI 0.3±0.3 1.1±0.5 0.007
A/(S+D) TVI 0.52±0.24 0.09±0.07 0.003
Indication No. of 
FE
% of 
FE
No. of Major 
anomalies
No. of Minor 
anomalies
Yield
(%)
Family history of CHD* 68 23 1 2 4
Maternal diabetes 55 18 2 2 7
Abnormal obstetrical US
(Suspicious for CHD)
46 15 15 1 35
Arrythmia 35 12 2 3 14
Extracardiac congenital 
anomalies
29 9 3 0 10
SLE/ +SSA/SSB 21 7 1 2 14
Chromosomal anomaly 18 6 5 4 50
Teratogen Exposure 14 5 0 0 0
Other 9 3 4 1 5
Advanced maternal age 4 1 0 0 0
Not ascertained 1 0.3 0 0 0
Total 300 99.3 33 15 16
